drug
as of 2026-07-01RO5545965
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Hoffmann-La Roche
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
3
A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics
NCT02824055Phase 1Completed
A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone
NCT02019329Phase 1Completed
A PET Study With RO5545965 in Healthy Male Volunteers
NCT01923025Phase 1Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication